Emotional Distress and Cardiovascular Disease Risk Among Participants Enrolled in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study

Overview

Journal Diabetes Res Clin Pract

Specialty Endocrinology

Date 2023 Jul 2

PMID 37394014

Authors

Gladys Crespo-Ramos

Ionut Bebu

Heidi Krause-Steinrauf

Claire J Hoogendoorn

Ran Fang

Dominic Ehrmann

Caroline Presley

Aanand D Naik

Aimee Katona

Elizabeth A Walker

Andrea Cherrington

Jeffrey S Gonzalez

Affiliations

Soon will be listed here.

Abstract

Aims: People with type 2 diabetes (T2DM) have an increased risk of cardiovascular disease (CVD). We examined depressive symptoms (DS) and diabetes distress (DD) in relation to the estimated 10-year risk of CVD in adults with T2DM enrolled in the GRADE Emotional Distress Substudy.

Methods: Linear regression models examined the associations of baseline DS and DD with estimated 10-year risk of CVD using the Atherosclerotic Cardiovascular Disease (ASCVD) risk score, adjusting for age, sex, race/ethnicity, education, income, diabetes duration, diabetes-related complications, and HbA1c.

Results: A total of 1,605 GRADE participants were included: 54% Non-Latino (NL) White, 18% Latino, 19% NL-Black, 66% male, mean age 57.5 (SD = 10.25) years, diabetes duration 4.2 (SD = 2.8) years, and HbA1c 7.5% (SD = 0.5%). After incorporating covariates, only DS, especially cognitive-affective symptoms, were associated with ASCVD risk (estimate = 0.15 [95% CI: 0.04, 0.025], p = 0.006). Higher DS remained significantly associated with higher ASCVD risk when adding DD to covariates (estimate = 0.19 [95% CI: 0.07, 0.30], p = 0.002). DD was not associated with ASCVD risk when accounting for covariates.

Conclusions: Depressive symptoms, particularly cognitive-affective symptoms, are associated with increased 10-year predicted ASCVD risk among adults with early T2DM. Diabetes distress is not significantly associated with the predicted ASCVD risk when accounting for covariates.

References

Lloyd-Jones D, Goff D, Stone N . Statins, risk assessment, and the new American prevention guidelines. Lancet. 2013; 383(9917):600-2. DOI: 10.1016/S0140-6736(13)62348-X. View

de Miranda Azevedo R, Roest A, Hoen P, de Jonge P . Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis. Psychol Med. 2014; 44(13):2689-703. DOI: 10.1017/S0033291714000063. View

Carney R, Blumenthal J, Catellier D, Freedland K, Berkman L, Watkins L . Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 2003; 92(11):1277-81. DOI: 10.1016/j.amjcard.2003.08.007. View

Bibbins-Domingo K, C Grossman D, Curry S, Davidson K, Epling Jr J, Garcia F . Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 316(19):1997-2007. DOI: 10.1001/jama.2016.15450. View

Winchester R, Williams J, Wolfman T, Egede L . Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes. J Diabetes Complications. 2015; 30(2):312-7. PMC: 4761313. DOI: 10.1016/j.jdiacomp.2015.11.010. View

Gonzalez J, Krause-Steinrauf H, Bebu I, Crespo-Ramos G, Hoogendoorn C, Naik A . Emotional distress, self-management, and glycemic control among participants enrolled in the glycemia reduction approaches in diabetes: A comparative effectiveness (GRADE) study. Diabetes Res Clin Pract. 2022; 196:110229. PMC: 9974790. DOI: 10.1016/j.diabres.2022.110229. View

Lloyd C, Pambianco G, Orchard T . Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-care in individuals with Type 1 diabetes?. Diabet Med. 2010; 27(2):234-7. PMC: 3093054. DOI: 10.1111/j.1464-5491.2009.02896.x. View

Gonzalez J, Delahanty L, Safren S, Meigs J, Grant R . Differentiating symptoms of depression from diabetes-specific distress: relationships with self-care in type 2 diabetes. Diabetologia. 2008; 51(10):1822-5. PMC: 2678064. DOI: 10.1007/s00125-008-1113-x. View

Cherrington A, Krause-Steinrauf H, Bebu I, Naik A, Walker E, Golden S . Study of emotional distress in a comparative effectiveness trial of diabetes treatments: Rationale and design. Contemp Clin Trials. 2021; 107:106366. PMC: 8667624. DOI: 10.1016/j.cct.2021.106366. View

10.

Wittkampf K, van Ravesteijn H, Baas K, van de Hoogen H, Schene A, Bindels P . The accuracy of Patient Health Questionnaire-9 in detecting depression and measuring depression severity in high-risk groups in primary care. Gen Hosp Psychiatry. 2009; 31(5):451-9. DOI: 10.1016/j.genhosppsych.2009.06.001. View

11.

Wiltink J, Michal M, Wild P, Schneider A, Konig J, Blettner M . Associations between depression and diabetes in the community: do symptom dimensions matter? Results from the Gutenberg Health Study. PLoS One. 2014; 9(8):e105499. PMC: 4134314. DOI: 10.1371/journal.pone.0105499. View

12.

Ye S, Muntner P, Shimbo D, Judd S, Richman J, Davidson K . Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: the REGARDS (Reason for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol. 2013; 61(6):622-30. PMC: 3568239. DOI: 10.1016/j.jacc.2012.09.058. View

13.

Arnett D, Blumenthal R, Albert M, Buroker A, Goldberger Z, Hahn E . 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 74(10):e177-e232. PMC: 7685565. DOI: 10.1016/j.jacc.2019.03.010. View

14.

Ohira T . Psychological distress and cardiovascular disease: the Circulatory Risk in Communities Study (CIRCS). J Epidemiol. 2010; 20(3):185-91. PMC: 3900839. DOI: 10.2188/jea.je20100011. View

15.

Polonsky W, Anderson B, Lohrer P, Welch G, Jacobson A, Aponte J . Assessment of diabetes-related distress. Diabetes Care. 1995; 18(6):754-60. DOI: 10.2337/diacare.18.6.754. View

16.

Fisher L, Glasgow R, Strycker L . The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care. 2010; 33(5):1034-6. PMC: 2858170. DOI: 10.2337/dc09-2175. View

17.

Hackett R, Steptoe A . Psychosocial Factors in Diabetes and Cardiovascular Risk. Curr Cardiol Rep. 2016; 18(10):95. PMC: 5002050. DOI: 10.1007/s11886-016-0771-4. View

18.

Cheng H, Ho M, Hung K . Affective and cognitive rather than somatic symptoms of depression predict 3-year mortality in patients on chronic hemodialysis. Sci Rep. 2018; 8(1):5868. PMC: 5897563. DOI: 10.1038/s41598-018-24267-5. View

19.

Sun G, Ye N, Wu S, Zhou Y, Sun Y . 10-year ASCVD risk is positively correlated with depressive symptoms in a large general population. BMC Psychiatry. 2019; 19(1):125. PMC: 6486683. DOI: 10.1186/s12888-019-2114-7. View

20.

Gonzalez J, Peyrot M, McCarl L, Collins E, Serpa L, Mimiaga M . Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008; 31(12):2398-403. PMC: 2584202. DOI: 10.2337/dc08-1341. View